To progress understanding of disease triggers and modifiers in sarcoidosis, stratification is the key

Coline H.M. van Moorsel

Source: Eur Respir J, 50 (6) 1702002; 10.1183/13993003.02002-2017
Journal Issue: December
Disease area: Interstitial lung diseases, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Coline H.M. van Moorsel. To progress understanding of disease triggers and modifiers in sarcoidosis, stratification is the key. Eur Respir J, 50 (6) 1702002; 10.1183/13993003.02002-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms
Source: Eur Respir J 2007; 29: 793-803
Year: 2007



Are genetic defects of dienin a key link in the pathogenesis of COPD?
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Towards understanding the role of autoreactivity in COPD
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011

Inflammatory pathways in COPD. What we know and potential clinical implications
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008


Advances in knowledge of global epidemiology, pathogenesis and risk factors
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008


Pathogenesis of occupational asthma, including genetic factors
Source: Annual Congress 2005 - Occupational asthma
Year: 2005

To the molecular genetic mechanisms of the COPD pathogenesis
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

The environment, epigenetics and lung disease
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013

Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020



Clinical relevance of COPD muscle dysfunction and body composition alterations, and their risk factors and underlying mechanisms
Source: International Congress 2016 – PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease
Year: 2016



Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019
Year: 2020



Impact of genetic factors on lung development in health and disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=93
Year: 2006

Role of hereditary predisposing factors in development of tuberculosis and its destructive forms
Source: Annual Congress 2008 - Difficult tuberculosis cases
Year: 2008

Understanding the heterogeneity of the disease
Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Year: 2015